PERTINENT FEATURES OF 11 LOCUS DETERMINANTS INCLUDING REVISED NOMENCLATURE AND STRAIN DISTRIBUTION = CARACTERISTIQUES PROPRES DES DETERMINANTS DU LOCUS M AVEC REVISION DE LA NOMENCLATURE ET DE LA DISTRIBUTION DANS LES SOUCHESFESTENSTEIN H.1974; TRANSPLANTATION; U.S.A.; DA. 1974; VOL. 18; NO 6; PP. 555-557; BIBL. 19REF.Article

¹⁴C-THYMIDINE RELEASE ASSAY: A NEW TEST FOR THE STUDY OF SURFACE DETERMINANTS ON ACTIVATED LYMPHOCYTESSCHIRRMACHER V; FESTENSTEIN H.1976; TISSUE ANTIGENS; DENM.; DA. 1976; VOL. 7; NO 3; PP. 183-186; BIBL. 4 REF.Article

MATERNAL HL-A ANTIBODIES AND FETAL SEXJOHANSEN K; FESTENSTEIN H.1974; BRIT. MED. J.; G.B.; DA. 1974; NO 5938; PP. 202-203; BIBL. 6REF.Article

The biological consequences of altered MHC expression on tumoursFESTENSTEIN, H.British medical bulletin. 1987, Vol 43, Num 1, pp 217-227, issn 0007-1420Article

VARIATION IN MHC ANTIGENIC PROFILES OF TUMOR CELLS AND ITS BIOLOGICAL EFFECTSFESTENSTEIN H; SCHMIDT W.1981; IMMUNOL. REV.; ISSN 0105-2896; DNK; DA. 1981; NO 60; PP. 85-127; BIBL. 5 P.Article

CELLULAR TYPINGBRADLEY BA; FESTENSTEIN H.1978; BRIT. MED. BULL.; GBR; DA. 1978; VOL. 34; NO 3; PP. 223-232; BIBL. 3 P.Article

Molecular features of the H-2 class I and Qa antigens expressed on gross virus induced AKR leukaemiasFESTENSTEIN, H.Journal of immunogenetics. 1989, Vol 16, Num 4-5, pp 329-333, issn 0305-1811Article

FURTHER EVIDENCE FOR DEREPRESSION OF H-2 AND IA-LIKE SPECIFITIES OF FOREIGN HAPLOTYPES IN MOUSE TUMOUR CELL LINES.GARRIDO F; FESTENSTEIN H.1976; NATURE; G.B.; DA. 1976; VOL. 261; NO 5562; PP. 705-707; BIBL. 21 REF.Article

INHIBITION OF CELL-DEPENDENT CYTOTOXICITY AS AN ASSAY FOR MOUSE ALLOANTIBODYHALLORAN P; FESTENSTEIN H.1974; NATURE; G.B.; DA. 1974; VOL. 250; NO 5461; PP. 52-54; BIBL. 13REF.Article

HLA GENOTYPING BY USING SPERMATOZOA. EVIDENCE FOR HAPLOID GENE EXPRESSION.ARNAIZ VILLENA A; FESTENSTEIN H.1976; LANCET; G.B.; DA. 1976; NO 7988; PP. 707-709; BIBL. 14 REF.Article

INHIBITION OF LYMPHOCYTE PROLIFERATIVE RESPONSES BY ANTI-HL-A ALLOANTISERA = INHIBITION DES REPONSES PROLIFERATIVES DES LYMPHOCYTES PAR DES ALLOANTISERUMS ANTI-HL-ABROCHIER J; ROITT IM; FESTENSTEIN H et al.1974; EUROP. J. IMMUNOL.; GERM.; DA. 1974; VOL. 4; NO 11; PP. 709-715; BIBL. 30REF.Article

CYTOSTATIC EFFECTOR CELLS GENERATED IN VIVO AGAINST M LOCUS DETERMINANTS.MATOSSIAN ROGERS A; FESTENSTEIN H.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 27; NO 2; PP. 335-339; BIBL. 11 REF.Article

MODIFICATION OF MURINE T-CELL CYTOTOXICITY BY PREIMMUNIZATION WITH M LOCUS AND H-2 INCOMPATIBILITIESMATOSSIAN ROGERS A; FESTENSTEIN H.1976; J. EXPER. MED.; U.S.A.; DA. 1976; VOL. 143; NO 2; PP. 456-461; BIBL. 18 REF.Article

GENETIC ANALYSIS OF THE MIXED LYMPHOCYTE REACTION IN H-1 SEROLOGICALLY IDENTICAL INBRED RATSBISHOP C; FESTENSTEIN H; KREN V et al.1978; J. IMMUNOGENET.; GBR; DA. 1978; VOL. 5; NO 5; PP. 323-334; BIBL. 15 REF.Article

IMMUNOGENETIC STUDIES ON METH-A-VACCINIA TUMOUR CELLS IN VIVO AND IN VITRO.GARRIDO F; SCHMIDT W; FESTENSTEIN H et al.1977; J. IMMUNOGENET.; G.B.; DA. 1977; VOL. 4; NO 2; PP. 115-125; BIBL. 1 P.Article

A FAMILY STUDY OF HLA ANTIGENS AND OTHER GENETIC MARKERS IN SCHIZOPHRENIAMCGUFFIN P; FESTENSTEIN H; MURRAY R et al.1983; PSYCHOLOGICAL MEDICINE; ISSN 0033-2917; GBR; DA. 1983; VOL. 13; NO 1; PP. 31-43; BIBL. 2 P.Article

MODIFICATION OF THE ANTI-TUMOUR IMMUNE RESPONSE BY SUPPRESSOR GENE PRODUCTS OF LYMPHOID CELLSDEGIORGI L; MATOSSIAN ROGERS A; FESTENSTEIN H et al.1979; IMMUNOLOGY; GBR; DA. 1979; VOL. 36; NO 4; PP. 711-718; BIBL. 21 REF.Article

MODULATION OF ANTIGEN EXPRESSION ON SPERM-ACTIVATED T CELLS IN CULTUREPACHOULA PAPASTERIADIS C; JARAQUEMADA D; FESTENSTEIN H et al.1979; TRANSPLANT. PROC.; USA; DA. 1979; VOL. 11; NO 2; PP. 1331; BIBL. 5 REF.Article

STUDIES ON H-2 SPECIFICITIES ON MOUSE TUMOUR CELLS BY A NEW MICRORADIOASSAY.GARRIDO F; SCHIRRMACHER V; FESTENSTEIN H et al.1977; J. IMMUNOGENET.; G.B.; DA. 1977; VOL. 4; NO 1; PP. 15-27; BIBL. 1 P.Article

A NEW SENSITIVE ASSAY FOR ANTIBODY AGAINST CELL SURFACE ANTIGENS BASED ON INHIBITION OF CELL DEPENDENT ANTIBODY MEDIATED CYTOTOXICITY. I. SPECIFITY AND SENSITIVITYHALLORAN P; SCHIRRMACHER V; FESTENSTEIN H et al.1974; J. EXPER. MED.; U.S.A.; DA. 1974; VOL. 140; NO 5; PP. 1348-1363; BIBL. 2 P.Article

DOMINANT ALLELE-SPECIFIC REGULATION OF EXPRESSION OF H-2K^K GENE PRODUCTS REVEALED BY SOMATIC CELL HYBRIDIZATIONBISHOP CE; LEWIS CM; FESTENSTEIN H et al.1982; SOMATIC CELL GENET.; ISSN 0098-0366; USA; DA. 1982; VOL. 8; NO 5; PP. 623-634; BIBL. 21 REF.Article

THE ROLE OF ANTIBODY IN THE INHIBITION OF THE GROWTH OF METH. A TUMOUR IN SYNGENEIC EXPERIMENTS IN VIVO AND IN VITROFARRAM E; FESTENSTEIN H; DE GIORGI L et al.1978; CLIN. EXPER. IMMUNOL.; GBR; DA. 1978; VOL. 33; NO 3; PP. 377-385; BIBL. 15 REF.Article

LOCATION OF MLS LOCUS ON MOUSE CHROMOSOME 1.FESTENSTEIN H; BISHOP C; TAYLOR BA et al.1977; IMMUNOGENETICS; GERM.; DA. 1977; VOL. 5; NO 4; PP. 357-361; BIBL. 7 REF.Article

SPECIFIC LYMPHOCYTE-ACTIVATING DETERMINANTS EXPRESSED ON MOUSE MACROPHAGESSCHIRRMACHER V; PENA MARTINEZ J; FESTENSTEIN H et al.1975; NATURE; G.B.; DA. 1975; VOL. 255; NO 5504; PP. 155-156; BIBL. 25REF.Article

PRECURSOR AND EFFECTOR PHENOTYPES OF ACTIVATED HUMAN T LYMPHOCYTESFAINBOIM L; NAVARRETE C; FESTENSTEIN H et al.1980; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1980; VOL. 288; NO 5789; PP. 391-393; BIBL. 27 REF.Article